Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

NCT04153760 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

257

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Postpartum Period
Aspirin

Interventions

DRUG: Aspirin 81 mg
DRUG: Placebo

Sponsor

University of Calgary

Collaborators

[object Object]
[object Object]